Micropaque Ct

Barium sulfate, the active ingredient in Micropaque Ct, is a contrast media presented as a suspension for oral and rectal use. It provides radiopaque contrast by attenuating X‑ray photons, enabling detailed imaging of the gastrointestinal tract during barium studies in patients requiring diagnostic radiology.

GNH USA supplies Micropaque Ct as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with a focus on quality assurance and regulatory compliance, and timely delivery to meet clinical needs across multiple regions.

Micropaque Ct, a barium sulfate suspension, is used in gastrointestinal imaging procedures. - Upper gastrointestinal (esophageal, gastric, duodenal) study: provides detailed radiographic images of the upper GI tract. - Lower gastrointestinal (colon) study: outlines the colon and rectum for evaluation of pathology. - Small‑bowel follow‑through: visualizes the small intestine to assess motility and structural abnormalities.

Adverse reactions may occur following administration of Micropaque Ct.

Common Side Effects: - Nausea: mild to moderate feeling of sickness. - Abdominal discomfort: cramping or fullness. - Diarrhea: loose stools after ingestion. - Constipation: difficulty passing stool. - Taste alteration: metallic or chalky sensation. - Mild vomiting: occasional emesis.

Serious or Rare Side Effects: - Allergic reaction: rash, itching, or anaphylaxis. - Severe abdominal pain: persistent or worsening pain. - Intestinal obstruction: blockage requiring medical attention. - Aspiration: inhalation of the suspension into the lungs. - Severe dehydration: excessive fluid loss after the procedure.

Before using Micropaque Ct, consider the following safety measures. - Assess patient history for bowel obstruction: avoid use in complete obstruction. - Confirm no known hypersensitivity to barium sulfate. - Ensure adequate hydration before and after administration. - Avoid use in patients with severe constipation without medical supervision. - Monitor for signs of aspiration in patients with dysphagia. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Micropaque Ct may interact with other agents used during diagnostic procedures.

Major Interactions (Avoid): - Concurrent use of oral iodine‑based contrast agents: may interfere with imaging interpretation. - Use with antacids containing aluminum or magnesium: can alter suspension consistency. - Combination with laxatives that cause rapid bowel evacuation: may reduce imaging quality.

Moderate Interactions (Monitor Closely): - Concomitant use of constipation‑inducing medications (e.g., opioids): may increase risk of bowel retention. - Use with anticholinergic agents: may affect gastrointestinal motility. - Co‑administration with diuretics: may impact patient hydration status.